Search clinical trials for: Serotonin Agents

Total 188159 results

Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S; Otsuka America Pharmaceutical

Completed

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

Schizophrenia

United States, Croatia, Latvia
Reviva Pharmaceuticals

Completed

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder (REFRESH)

Schizoaffective Disorder | Acute Schizophrenia

United States, India, Malaysia, Moldova, Republic of, Philippines
Bristol-Myers Squibb
Otsuka America Pharmaceutical

Completed

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Massachusetts General Hospital

Terminated

Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents

Pediatric Bipolar Disorder

United States
Clinvest
Merck Sharp & Dohme LLC

Completed

Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine

Headache, Migraine

United States
Universita di Verona

Unknown

Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia (CHAT)

Schizophrenia

Italy
University Ghent
University Hospital, Ghent

Completed

Stepped Care aiTBS 2 Depression Study (Ghent) (aiTBS2-Ghent)

Depressive Disorder, Major | Treatment Resistant Depression | Melancholia

Belgium
University Hospital, Basel, Switzerland

Recruiting

Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache (LCH)

Cluster Headache

Switzerland
Universidade Federal do Rio Grande do Norte

Completed

Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression

Depressive Disorder | Depression, Unipolar

Brazil
Algernon Pharmaceuticals
Centre for Human Drug Research, Netherlands

Active, not recruiting

Single and Repeat Doses of DMT in Healthy Subjects

Stroke

Netherlands
Zosano Pharma Corporation

Completed

Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine (Zotrip)

Acute Migraine

United States
Procter and Gamble

Terminated

Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation

Chronic Constipation

United States, Canada
M.D. Anderson Cancer Center
Eisai Inc.

Completed

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

Melanoma

United States
Danish Headache Center

Completed

PACAP38 Induced Headache and Rosacea-like Symptoms in Patients With Rosacea

Rosacea

Denmark
Movetis
FOCUS GmbH

Completed

M0001 Effects on Oral Contraceptive Plasma Levels

Healthy Volunteers

Germany
H. Lundbeck A/S

Completed

Investigating the Effect of Vortioxetine in Adult ADHD Patients

Attention Deficit Hyperactivity Disorder

United States
Tianjin Medical University General Hospital
Shanghai Mental Health Center; Nanjing Medical University; First Affiliated Hospital... and other collaborators

Unknown

Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals

Schizophrenia | Anxiety Disorders | Major Depressive Disorder

China
Medical University of Vienna

Completed

Therapeutic Drug Monitoring in Child and Adolescent Psychiatry (TDMKJP)

Depression | Anorexia Nervosa | ADHD

Austria
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia

Schizophrenia

United States
Shanghai Mental Health Center

Withdrawn

Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder
Otsuka Beijing Research Institute

Completed

Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia

Schizophrenia

China
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

Bipolar I Disorder

United States, Taiwan, Romania, Korea, Republic of, Japan, Poland, Canada
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole

Nervous System Diseases | Schizophrenia | Mental Disorder

United States
H. Lundbeck A/S
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole Once-monthly in Patients With Schizophrenia

Schizophrenia

United States
CMG Pharmaceutical Co. Ltd

Completed

Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers

Schizophrenia
Wei Hao

Terminated

An Study of Aripiprazole in the Treatment of Methamphetamine Dependence

Methamphetamine Dependence

China
Otsuka Pharmaceutical Development & Commercialization...
Covance

Completed

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia (ASPIRE)

Schizophrenia

Spain, Korea, Republic of, United States, Russian Federation, Chile, Estonia, Finland, Mexico, Hungary, Bulgaria, Croatia, Serbia, France, Poland, Romania, Thailand, Puerto Rico, Slovakia, Taiwan, Australia, India, Argentina, South... and more
Duke University
Bristol-Myers Squibb

Completed

Metabolic Signatures and Biomarkers in Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia

Psychotic Disorders | Schizophrenia
Taichung Veterans General Hospital

Unknown

Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine (HeartAriQue)

Schizophrenia | Bipolar

Taiwan
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

Finland, Germany, Korea, Republic of, United States, Taiwan, Estonia, India, Italy, Mexico
University Health Network, Toronto
University of British Columbia; McGill University; Centre for Addiction and Mental... and other collaborators

Completed

Canadian Biomarker Integration Network for Depression Study (CAN-BIND-1)

Major Depressive Disorder

Canada
University of Calgary
Janssen Inc.

Completed

Prucalopride Versus Placebo in Gastroparesis

Diabetes Mellitus | Gastroparesis

Canada
University of British Columbia

Unknown

Prucalopride Prior to Small Bowel Capsule Endoscopy

Intestinal Diseases | Inflammatory Bowel Diseases | Celiac Disease | Crohn Disease | Gastrointestinal Hemorrhage

Canada
NuPathe Inc.

Completed

Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers (NP101-006)

Migraine Disorders

United States
Pfizer

Completed

A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack

Migraine

United States
Teva Pharmaceuticals USA

Completed

Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions

Healthy

Canada
Movetis

Completed

Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing Facility

Constipation
University of Fribourg

Recruiting

Effects of LSD on Neuroplasticity in Healthy Subjects

Healthy

Switzerland
Sanofi

Completed

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Alzheimer Disease

United States, Canada
Takeda

Completed

Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy Volunteers

Healthy Volunteers

United States
Dr. Falk Pharma GmbH

Recruiting

Different Doses of Naronapride vs. Placebo in Gastroparesis (MOVE-IT)

Gastroparesis

Belgium
Instituto Nacional de Cancer, Brazil

Completed

Compare Between Two Doses of Palonosetron on the Prevention of Postoperative Nausea and Vomiting in Obese Patients

Postoperative Nausea and Vomiting

Brazil
Duke University

Completed

Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone

Major Depressive Disorder (MDD)

United States
University of Chicago

Completed

Double-Blind Treatment of Major Depressive Disorder With Vilazodone

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Terminated

To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States, Australia, Bulgaria, Romania, India, Slovakia, Philippines
Jinling Hospital, China

Completed

Prucalopride for Postoperative Ileus in Patients Undergoing Gastrointestinal Surgery

Postoperative Ileus

China
Adams Clinical

Completed

Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse Study (TRAIT-RS)

Major Depressive Disorder

United States

Search clinical trials for: Serotonin Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations